ReviewSeminars in cancer biology2018
The FOXO3-FOXM1 axis: A key cancer drug target and a modulator of cancer drug resistance.
Shang Yao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
131 papers cite itlatest 60 shown
this papertrialcites it